[{"Assets_0_Q1_USD":133565000.0,"EarningsPerShareBasic_1_Q1_USD":0.66,"EarningsPerShareDiluted_1_Q1_USD":0.61,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":2326000.0,"NetIncomeLoss_1_Q1_USD":4607000.0,"StockholdersEquity_0_Q1_USD":92698000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":7594000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":7011000.0,"Ticker":"HSKA","CIK":"1038133","name":"HESKA CORP","OfficialName":"Heska Corporation Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1478587375.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20170505"}]